Lambert, Anna Tancin
Sætre, Dag Ottar
Ratajczak-Tretel, Barbara
Gleditsch, Jostein
Høie, Gudrun
Al-Ani, Riadh
Pesonen, Maiju
Atar, Dan
Aamodt, Anne Hege http://orcid.org/0000-0002-2824-2760
Funding for this research was provided by:
Helse Sør-Øst RHF (2019020)
Østfold Hospital Trust
Article History
Received: 16 March 2024
Revised: 18 April 2024
Accepted: 22 April 2024
First Online: 21 June 2024
Declarations
:
: DA has received honoraria and consultation fees from Actelion, Amgen, AstraZeneca, BMS, Bayer, Boehringer Ingelheim, MSD, Novartis, Pharmacosmos, Philips, Pfizer, Roche Diagnostics, Sanofi, Takeda, and Vifor Pharma, and research funding (to the institution) from BMS/Pfizer, Bayer, Roche Diagnostics and Medtronic. AHA has received travel support, and honoraria for advice or lecturing from Bayer, Boehringer Ingelheim, BMS, Abbvie, Teva, Novartis, Roche, Pfizer, and Teva, research grant from Boehringer Ingelheim, and partial financial support from Medtronic and BMS for operating costs in ongoing clinical studies. ATL and BRT have received travel funding from Medtronic and are funded by a PhD fellowship from Helse Sør-Øst (South-Eastern Norway Regional Health Authority).